(Q38016798)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674489%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

title

New vistas for treatment of obesity and diabetes? Endocannabinoid signalling and metabolism in the modulation of energy balance (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674489%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674489%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author name string

Wiebke Rastedt

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674489%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Andrew J Irving

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674489%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Harinder S Hundal

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674489%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

language of work or name

English

0 references

publication date

5 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674489%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674489%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674489%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674489%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

page(s)

681-691

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674489%20AND%20SRC:MED&resulttype=core&format=json

The endogenous cannabinoid system and the treatment of marijuana dependence

3 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Activation of the peripheral endocannabinoid system in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

2-Arachidonoylglycerol and the cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Endocannabinoid structure-activity relationships for interaction at the cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

The orphan receptor GPR55 is a novel cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

The expression of receptors for endocannabinoids in human and rodent skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Monoglyceride lipase deficiency in mice impairs lipolysis and attenuates diet-induced insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

The N-acylethanolamine-hydrolyzing acid amidase (NAAA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Temporal and site-specific brain alterations in CB1 receptor binding in high fat diet-induced obesity in C57Bl/6 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Effects of in vitro antagonism of endocannabinoid-1 receptors on the glucose transport system in normal and insulin-resistant rat skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Regulation of MAP kinase-directed mitogenic and protein kinase B-mediated signaling by cannabinoid receptor type 1 in skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

SR141716A is an inverse agonist at the human cannabinoid CB1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Hormonal regulation of food intake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Involvement of hypothalamic peptides in the anorectic action of the CB receptor antagonist rimonabant (SR 141716).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Endocannabinoid signaling system and brain reward: emphasis on dopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Appetite suppression and weight loss after the cannabinoid antagonist SR 141716.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Anti-obesity efficacy of LH-21, a cannabinoid CB(1) receptor antagonist with poor brain penetration, in diet-induced obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Identification of endocannabinoids and related compounds in human fat cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Effect of the Cannabinoid Receptor-1 antagonist SR141716A on human adipocyte inflammatory profile and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Anandamide increases the differentiation of rat adipocytes and causes PPARgamma and CB1 receptor upregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Modulation of adipocyte biology by δ(9)-tetrahydrocannabinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Cannabinoid receptor stimulation impairs mitochondrial biogenesis in mouse white adipose tissue, muscle, and liver: the role of eNOS, p38 MAPK, and AMPK pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Reversal of inflammation-induced impairment of glucose uptake in adipocytes by direct effect of CB1 antagonism on adipose tissue macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Activated endocannabinoid system in coronary artery disease and antiinflammatory effects of cannabinoid 1 receptor blockade on macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Is lipid signaling through cannabinoid 2 receptors part of a protective system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

The cannabinoid CB1 receptor antagonist rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating the expression of phosphatidylinositol-3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Cannabinoids induce pancreatic β-cell death by directly inhibiting insulin receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Targeting of PKCzeta and PKB to caveolin-enriched microdomains represents a crucial step underpinning the disruption in PKB-directed signalling by ceramide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Rimonabant, a cannabinoid receptor type 1 inverse agonist, inhibits hepatocyte lipogenesis by activating liver kinase B1 and AMP-activated protein kinase axis downstream of Gα i/o inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Cannabinoid receptor type 1 (CB1R) signaling regulates hepatic gluconeogenesis via induction of endoplasmic reticulum-bound transcription factor cAMP-responsive element-binding protein H (CREBH) in primary hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Inhibitory effect of the cannabinoid receptor agonist WIN 55,212-2 on pentagastrin-induced gastric acid secretion in the anaesthetized rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Cannabinoids and the gut: new developments and emerging concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta-cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Presence of functional cannabinoid receptors in human endocrine pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Cannabinoids inhibit insulin secretion and cytosolic Ca2+ oscillation in islet beta-cells via CB1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Cannabinoid receptors are coupled to stimulation of insulin secretion from mouse MIN6 beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Cannabinoid receptor agonists and antagonists stimulate insulin secretion from isolated human islets of Langerhans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Identification of N-arachidonylglycine, U18666A, and 4-androstene-3,17-dione as novel insulin Secretagogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

G1359A polymorphism in the cannabinoid receptor-1 gene is associated with metabolic syndrome in the Chinese Han population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Leptin-regulated endocannabinoids are involved in maintaining food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Acute overactive endocannabinoid signaling induces glucose intolerance, hepatic steatosis, and novel cannabinoid receptor 1 responsive genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Krill oil significantly decreases 2-arachidonoylglycerol plasma levels in obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Effect of rimonabant on the high-triglyceride/ low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

CNS opioid signaling separates cannabinoid receptor 1-mediated effects on body weight and mood-related behavior in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Blockade of central cyclooxygenase (COX) pathways enhances the cannabinoid-induced antinociceptive effects on inflammatory temporomandibular joint (TMJ) nociception.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

Metabolism of anandamide by COX-2 is necessary for endocannabinoid-induced cell death in tumorigenic keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

The atypical cannabinoid O-1602 stimulates food intake and adiposity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

The L-α-lysophosphatidylinositol/GPR55 system and its potential role in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031

The G1422A variant of the cannabinoid receptor gene (CNR1) is associated with abdominal adiposity in obese men

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.201200031